Home / ETFis Series Trust I / Virtus Biotech ETF
Virtus Biotech ETF
A series of ETFis Series Trust I
- Vote records
- 571year to 30 June 2026
- Against management
- 17.7%101 of 571 marked votes
- Say-on-pay support
- 76.4%for, of for + against + abstain
- Shareholder-proposal support
- 20.0%for, of for + against + abstain
Virtus Biotech ETF is a series of ETFis Series Trust I. For the year to 30 June 2026 its registrant reported 571 vote records for the series; 17.7% of the votes marked for or against management went against management. It voted for 76.4% of say-on-pay items and for 20.0% of proposals from security holders.
Compared with its registrant
| year to 30 June 2026 | This series | Its registrant | Median fund registrant |
|---|---|---|---|
| Against-management share | 17.7% | 9.9% | 6.2% |
| Say-on-pay support rate | 76.4% | 89.8% | 91.6% |
| Shareholder-proposal support rate | 20.0% | 19.7% | 27.5% |
Votes by category
foragainstabstain, withhold or otheramber tick: the portion cast against management
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 293 | 241 | 11 | 17.7% | |
| SECTION 14A SAY-ON-PAY VOTES | 122 | 84 | 26 | 21.3% | |
| AUDIT-RELATED | 64 | 64 | 0 | 0.0% | |
| EXTRAORDINARY TRANSACTIONS | 2 | 2 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 15 | 13 | 2 | 13.3% | |
| COMPENSATION | 49 | 33 | 16 | 32.7% | |
| CORPORATE GOVERNANCE | 30 | 23 | 7 | 20.0% | |
| ENVIRONMENT OR CLIMATE | 2 | 1 | 1 | 0.0% | |
| HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE | 1 | 1 | 0 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 2 | 1 | 1 | 0.0% | |
| OTHER SOCIAL ISSUES | 4 | 2 | 2 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|---|
| year to 30 June 2025 | 681 | 16.0% | 80.7% | 33.3% |
| year to 30 June 2026 | 571 | 17.7% | 76.4% | 20.0% |
Questions
How often did Virtus Biotech ETF vote against management?
17.7% of the votes its registrant marked for or against management in the year to 30 June 2026 (101 of 571).
How did Virtus Biotech ETF vote on executive pay?
It voted for 84 of 110 say-on-pay items cast for, against or abstain (76.4%).
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other shareholders voted or what the outcome was.
Where does the data come from?
From the Form N-PX filed by ETFis Series Trust I, which lists the series that cast each vote. The SEC does not verify the contents. Data runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX filed by ETFis Series Trust I (filer no. 1559109); votes attributed to series S000047354 by the filer. Not verified by the SEC. Filings read through 23 Sep 2026.